ETFs & Funds
This user currently has no profile.
My investment thesis is that Cancer will be cured in this decade and the
Magnificent Seven will move us toward the goal CTIX NWBO PCYC THLD SNTA IMUC SBFM
The next Wave will be Regenerative Medicine and a group of biotechs I call the
Cell Biology Seven will lead that wave. ISCO is now the leader of that group and
may become the dominant supplier to others in the field in the same manner that
MSFT came to dominate computer operating systems in prior decades.
The other six are BTX MEDS NNVC BCLI ARWR SRPT
Independent / boutique research firm analyst.
Dividend stock ideas & income, Energy stocks, Options, Stocks - long
Currently, there is no company profile for biomanbaba.
Currently, there are no blog details for biomanbaba.
Currently, there are no book details for biomanbaba.
timeline improving lately
Oct 5, 2013
Retiredpharma:It appears th...
3 Reasons To Stay Far Away From Synta Pharmaceu...
The balance of the NYT arti...
Observations From My Trip To China
umiak1:A damn good idea. I ...
Navidea: Positive News And Short Interest Trend
KarinCA Thank you for your ...
NeoStem: An Investment In 4 Different Divisions
Extraordinary and timely......
What Everyone Must Know About Currencies: Profi...